Breast Cancer Screening Market

Breast Cancer Screening Market Segmentation, Size, Share, Trends, Growth, Value, Demand, and Company Profile Analysis Forecast Report 2021-2026 | COVID-19 Impact on the Global Market

1. Preface
1.1 Market Definition and Scope
1.2 Base Currency, Base Year and Forecast Periods
1.3 Key Research Objectives
1.4 Research Highlights
2. General Study Assumptions
3. Research Methodology
3.1 Introduction
3.2 Secondary Research
3.3 Primary Research
3.4 Analysis Design
3.5 Study Timeline
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Market Trends
5. Supply Chain Analysis
6. Company Strategy Analysis
6.1 Merger and Acquisition Analysis
6.2 Agreements, Collaborations and Joint Ventures
6.3 Regional Presence
6.4 New Product Launches
7. Market Outlook
7.1 Technological Advancement
7.2 Pricing Analysis
7.3 Epidemiology
7.4 Product Landscape Analysis (Brand Tracking Analysis & Pipeline Analysis)
8. Market Segmentation
8.1 Overview
8.2 Global Breast Cancer Screening Market, By Type, forecast year 2021-2026
8.2.1 Imaging
8.2.2 Biopsy
8.2.3 Genomic Tests
8.2.4 Blood Tests
8.2.5 Others
8.2.6 Market Size Estimations & Forecasts (2021-2026)
8.2.7 Y-o-Y Growth Analysis
8.2.8 Market Investment Opportunities Analysis
8.3 Global Breast Cancer Screening Market, By Product, forecast year 2021-2026
8.3.1 Platform-based Products
8.3.1.1 Next-generation Sequencing
8.3.1.2 Microarrays
8.3.1.3 PCR
8.3.1.4 Others
8.3.2 Instrument-based Products
8.3.2.1 Imaging
8.3.2.2 Biopsy
8.3.3 Market Size Estimations & Forecasts (2021-2026)
8.3.4 Y-o-Y Growth Analysis
8.3.5 Market Investment Opportunities Analysis
8.4 Global Breast Cancer Screening Market, By Application, forecast year 2021-2026
8.4.1 Screening
8.4.2 Diagnostic and Predictive
8.4.3 Prognostic
8.4.4 Research
8.4.5 Market Size Estimations & Forecasts (2021-2026)
8.4.6 Y-o-Y Growth Analysis
8.4.7 Market Investment Opportunities Analysis
8.5 Global Breast Cancer Screening Market, By End-User, forecast year 2021-2026
8.5.1 Hospitals & Clinics
8.5.2 Diagnostic Centers and Medical Laboratories
8.5.3 Others
8.5.4 Market Size Estimations & Forecasts (2021-2026)
8.5.5 Y-o-Y Growth Analysis
8.5.6 Market Investment Opportunities Analysis
9. Market Regional and Country Analysis, Forecast 2021-2026
9.1 Overview
9.2 Regional Trends
9.3 Impact Analysis
9.4 Key Findings
9.5 Global Breast Cancer Screening Market, by Region, 2021-2026
9.5.1 By Type
9.5.2 By Product
9.5.3 By Application
9.5.4 By End-User
10. Competitive Landscape Analysis
10.1 Market Player
10.1.1 Company Revenue
10.1.2 Business unit
10.1.3 Product Mapping
10.1.4 Geographical Locations
10.2 Company Share Analysis
11. Strategic Analysis
11.1 PESTLE analysis
11.2 Porter’s Five analysis
11.2.1 Bargaining Power of Suppliers
11.2.2 Bargaining Power of Consumers
11.2.3 Threat of New Entrants
11.2.4 Threat of Substitute Products and Services
11.2.5 Competitive Rivalry within the Industry
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Overview
12.1.2 Product Portfolio
12.1.3 Financial Details
12.1.4 SWOT Analysis
12.1.5 Market Strategies
12.2 Myriad Genetics Inc
12.3 Hologic Inc
12.4 Koninklijke Philips N.V.
12.5 Fujifilm Holdings Corporation
12.6 GE Healthcare
12.7 Thermo Fischer Scientific Inc
12.8 Siemens AG
12.9 NanoString Technologies Inc
12.10 C. R. Bard Inc
13. Market Guidance
14. Appendix

    1. Abbott Laboratories
    2. Myriad Genetics Inc
    3. Hologic Inc
    4. Koninklijke Philips N.V.
    5. Fujifilm Holdings Corporation
    6. GE Healthcare
    7. Thermo Fischer Scientific Inc
    8. Siemens AG
    9. NanoString Technologies Inc
    10. C. R. Bard Inc